4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerLow Grade Serous Ovarian CancerRecruitingPhase 32026-10-07NCT06072781
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edemaeye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorderRecruitingPhase 22026-10-01NCT06962839
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has SpreadDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, esophageal adenocarcinoma, gastroesophageal junction adenocarcinoma, intestinal disorder, neoplasm, rectal disorder, skin disorderRecruitingPhase 1 / Phase 22026-09-30NCT06324357
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 AlterationsSolid TumoursRecruitingPhase 22026-09-29NCT06581432